Oscar Health, Inc. (NYSE:OSCR) Shares Sold by Two Sigma Advisers LP

Two Sigma Advisers LP trimmed its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 10.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,175,100 shares of the company's stock after selling 138,400 shares during the period. Two Sigma Advisers LP owned about 0.49% of Oscar Health worth $24,924,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also added to or reduced their stakes in OSCR. Simplicity Wealth LLC purchased a new position in Oscar Health during the second quarter valued at approximately $179,000. SG Americas Securities LLC grew its holdings in Oscar Health by 900.6% in the second quarter. SG Americas Securities LLC now owns 190,039 shares of the company's stock worth $3,006,000 after purchasing an additional 171,047 shares during the last quarter. Assenagon Asset Management S.A. lifted its stake in shares of Oscar Health by 32.9% during the second quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company's stock worth $32,368,000 after buying an additional 507,009 shares during the period. Raymond James & Associates acquired a new stake in shares of Oscar Health during the second quarter worth $3,168,000. Finally, Hennessy Advisors Inc. acquired a new stake in shares of Oscar Health during the second quarter worth $9,047,000. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Price Performance

Shares of OSCR stock traded down $0.79 on Friday, reaching $15.61. 5,744,764 shares of the company were exchanged, compared to its average volume of 5,015,905. The company has a market cap of $3.86 billion, a price-to-earnings ratio of -260.12 and a beta of 1.63. The business has a 50-day moving average price of $16.90 and a 200 day moving average price of $17.84. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. Oscar Health, Inc. has a 1 year low of $7.50 and a 1 year high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business had revenue of $2.42 billion for the quarter, compared to analysts' expectations of $2.33 billion. During the same period in the prior year, the company posted ($0.29) EPS. The firm's revenue was up 68.3% on a year-over-year basis. Equities research analysts forecast that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Mario Schlosser sold 6,516 shares of the company's stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $117,809.28. Following the transaction, the insider now directly owns 81,962 shares in the company, valued at approximately $1,481,872.96. This represents a 7.36 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CAO Victoria Baltrus sold 8,078 shares of the company's stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $146,050.24. Following the completion of the transaction, the chief accounting officer now owns 146,036 shares in the company, valued at approximately $2,640,330.88. This represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders bought 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. Corporate insiders own 25.11% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on OSCR. UBS Group began coverage on shares of Oscar Health in a research report on Monday, October 7th. They set a "neutral" rating and a $23.00 target price for the company. Piper Sandler reiterated an "overweight" rating and issued a $28.00 price objective on shares of Oscar Health in a research report on Tuesday, September 10th. Finally, Bank of America downgraded shares of Oscar Health from a "neutral" rating to an "underperform" rating and decreased their price objective for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $22.93.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.